BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25797371)

  • 1. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
    Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
    Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T11TS Treatment Augments Apoptosis of Glioma Associated Brain Endothelial Cells, Hint Toward Anti-Angiogenic Action in Glioma.
    Bhattacharya D; Singh MK; Chaudhuri S; Datta A; Chaudhuri S
    J Cell Physiol; 2017 Mar; 232(3):526-539. PubMed ID: 27255231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro-survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells.
    Bhattacharya D; Singh MK; Chaudhuri S; Acharya S; Basu AK; Chaudhuri S
    J Neurooncol; 2013 May; 113(1):13-25. PubMed ID: 23471571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
    Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
    Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf.
    Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA
    Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways.
    Liu Z; Jiang Z; Huang J; Huang S; Li Y; Yu S; Yu S; Liu X
    Int J Oncol; 2014 May; 44(5):1571-80. PubMed ID: 24603851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H; Shimizu K
    Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus (FK506) inhibits interleukin-1β-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes.
    Choe JY; Lee SJ; Park SH; Kim SK
    Joint Bone Spine; 2012 Mar; 79(2):137-43. PubMed ID: 21550286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
    Wilhelm SM; Carter C; Tang L; Wilkie D; McNabola A; Rong H; Chen C; Zhang X; Vincent P; McHugh M; Cao Y; Shujath J; Gawlak S; Eveleigh D; Rowley B; Liu L; Adnane L; Lynch M; Auclair D; Taylor I; Gedrich R; Voznesensky A; Riedl B; Post LE; Bollag G; Trail PA
    Cancer Res; 2004 Oct; 64(19):7099-109. PubMed ID: 15466206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Ras/MEK/ERK signaling in chronic subdural hematoma outer membranes.
    Osuka K; Watanabe Y; Usuda N; Atsuzawa K; Aoyama M; Niwa A; Nakura T; Takayasu M
    Brain Res; 2012 Dec; 1489():98-103. PubMed ID: 23063714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
    Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
    Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling.
    Harfouche R; Malak NA; Brandes RP; Karsan A; Irani K; Hussain SN
    FASEB J; 2005 Oct; 19(12):1728-30. PubMed ID: 16049136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
    Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
    Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1-dependent function in endothelial cells.
    Onimaru M; Yonemitsu Y; Suzuki H; Fujii T; Sueishi K
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):818-26. PubMed ID: 20056911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway.
    Zheng J; Du W; Song LJ; Zhang R; Sun LG; Chen FG; Wei XT
    World J Surg Oncol; 2014 Jul; 12():207. PubMed ID: 25022352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.
    Motta C; D'Angeli F; Scalia M; Satriano C; Barbagallo D; Naletova I; Anfuso CD; Lupo G; Spina-Purrello V
    Eur J Pharmacol; 2015 Aug; 761():55-64. PubMed ID: 25934569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.